Apoptosis is a distinct mode of programmed cell death whereby cellular contents are broken down and accumulated in the apoptotic bodies. The vast majority of the genome consists of non-coding RNAs (ncRNA). NcRNAs can be divided into groups depending on their length, for example, long non-coding RNA (lncRNA) longer than 200 nucleotides. It has been demonstrated that these have important roles in the development, and treatment of cancer and in other diseases that critically affect human life. Considering the lncRNAs’ mechanisms of action on apoptosis, they modulate activity of transcription factors, regulate miRNAs, and interact with proteins related to histone mechanisms such as chromatin modifier. In this perspective, GTF2A1-AS which is an uncharacterized and novel lncRNA was found as one of highly expressed lncRNA in transcriptomic data obtained from HeLa cells treated with cisplatin. The potential role of GTF2A1-AS within the cell was investigated through the transcriptomic data provided by GTF2A1-AS knockdown. It has been found that specific gene clusters mainly enriched in the pathway which is Defective Homology directed Repair through Homologous Recombination. In this process, double-strand breaks are repaired with the help of BRCA1/2, RAD50, RAD51, PALB2 proteins which are known as DNA damage response proteins. Thus, the genes related with DNA damage response were selected to validate the transcriptomic data. In light of this information, GTF2A1-AS knockdown has resulted in an increase in the early apoptosis in HeLa cells. Additionally, when GTF2A1-AS knockdown was combined with cisplatin, it sensitized HeLa cells against cisplatin by affecting late apoptosis, specifically. Consequently, GTF2A1-AS as a cisplatin inducible lncRNA modulates apoptosis and chemosensitivity in HeLa cells.